B12 And Verbal Recall — The Connection Most People Miss
Quick Read Struggling to find a word or remember someone’s name may feel like normal ageing, but research suggests it’s
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
CoQ10 is a compound your body produces naturally that helps cells generate energy and protects them from damage. Your body makes less of it as you age, particularly after your mid-twenties. Since the brain uses enormous amounts of energy and is vulnerable to damage, declining CoQ10 levels could theoretically contribute to brain fog, sluggishness, and cognitive decline.
Research shows meaningful connections. A study of 64 older adults found that higher CoQ10 levels were linked with better memory and mental flexibility, independent of fitness or nutrition. A meta-analysis of five randomized trials involving 474 people found that CoQ10 supplementation produced moderate improvements in depression symptoms. Evidence also suggests CoQ10 may help with brain fog related to chronic fatigue, long COVID, and viral illness, since these conditions involve the same energy production problems in brain cells.
The evidence is promising but not conclusive in healthy adults. Studies on animals show CoQ10 protects brain cells in neurodegenerative diseases, but human trials are still ongoing. CoQ10 is well-tolerated with no known toxicity at normal doses, and typical supplementation ranges from 100mg to 300mg daily, best taken with fat for absorption.
Verdict: If you’re over 40 and experiencing brain fog, fatigue, or flat mood, especially after illness or while on statins, CoQ10 supplementation is biologically sound and has a favorable safety profile, though you should consult your doctor first.
What if the fuzzy thinking, sluggishness and mental slowdown you’ve been quietly chalking up to “just getting older” were actually a sign that your brain’s energy production system is running low on one of its most essential components? Brain fog is one of those frustrating experiences that’s genuinely hard to describe to a doctor, not quite fatigue, not quite sadness, not quite confusion, but a bit of all three. You know your mind isn’t firing the way it used to, but the cause feels elusive. Here’s a question worth sitting with: could a gradual decline in CoQ10, a compound your own body makes, and makes less of as you age, be quietly dimming the lights in your brain?
Vitacuity has reviewed over 1.77 million research papers and selected the most relevant studies on this topic. What the evidence shows is genuinely interesting, and more nuanced than the supplement industry typically admits.
CoQ10, formally known as Coenzyme Q10, or ubiquinone, is a fat-soluble compound found in virtually every cell in your body, but it’s particularly concentrated in tissues that have the highest energy demands: your heart, your muscles, and your brain [6].
Here’s the key thing to understand about what CoQ10 actually does. Inside each of your cells are tiny structures called mitochondria, you may remember them from school as “the powerhouse of the cell.” That description is accurate. Mitochondria convert the food you eat into ATP, the molecule your cells actually run on. CoQ10 sits at the very centre of this process, acting as an electron carrier in what’s called the mitochondrial electron transport chain. Without it, this energy production line effectively grinds to a halt [10].
But CoQ10 plays a second, equally important role: it’s your body’s only fat-soluble antioxidant that cells can manufacture themselves [14]. That matters because your brain is rich in fats and burns through an enormous amount of oxygen, a combination that makes it unusually vulnerable to damage from oxidative stress (essentially, cellular rust caused by unstable molecules called free radicals). CoQ10 neutralises these free radicals and helps recycle other antioxidants like vitamin E [10].
Now here’s where ageing enters the picture. Your body’s natural production of CoQ10 peaks in your mid-twenties and declines steadily from there [6]. By the time you reach your 50s and 60s, levels have dropped meaningfully, and the brain regions responsible for memory, focus, and executive function may be among the first to feel it.
CoQ10 exists in three forms in the body: ubiquinol (the reduced, active antioxidant form), ubiquinone (the oxidised form), and a semiquinone radical state in between. The interplay between these forms is central to both its energy and antioxidant functions [6].
Evidence grade: Promising, human observational data, but small sample
One of the most directly relevant studies for anyone concerned about cognitive decline comes from a 2023 Spanish study involving 64 older adults aged 65–99 years (average age 76.67) [7]. Researchers measured plasma CoQ10 levels alongside cognitive functioning and executive function, the mental skills involved in planning, attention and mental flexibility.
The headline finding: plasma CoQ10 was significantly associated with both overall cognitive functioning and executive function, even after controlling for physical activity levels and nutritional status. In other words, the relationship between CoQ10 and cognitive sharpness held up independently, it wasn’t simply that healthier, more active people happened to have higher CoQ10 [7].
The researchers concluded that a decline in cognitive capacities may be meaningfully related to reduced antioxidant defences, with CoQ10 as a key marker of those defences. This is a cross-sectional study of 64 people, so we’re not at the level of “CoQ10 definitely protects your brain”, but it’s a genuinely compelling association that points in a consistent direction with the biological evidence [7].
Evidence grade: Promising, meta-analysis of five RCTs, 474 participants
Brain fog and low mood are closely related in practice, and this is an area where the evidence for CoQ10 has taken an interesting step forward. A 2026 systematic review and meta-analysis, which is considered the gold standard of evidence because it pools results from multiple trials, analysed five randomised controlled trials involving 474 participants [3].
The finding on depressive symptoms was meaningful: CoQ10 supplementation produced a standardised mean difference (SMD) of -0.68 compared to placebo, which translates to a moderate effect size. The result was statistically significant (P <0.01), and the effect held across different rating scales used to measure depression [3].
It’s worth being clear about what this population looked like. Three of the five trials enrolled people with depression connected to other medical conditions, multiple sclerosis, breast cancer, and polycystic ovary syndrome. The remaining two studied people with primary depression (major depression and bipolar disorder). So this isn’t exclusively a healthy-ageing population, but the consistency across such varied conditions is itself interesting, suggesting CoQ10’s mechanism (reducing mitochondrial dysfunction and oxidative stress) may be relevant across different types of depressive illness [3].
The fatigue finding was less clear-cut. The same meta-analysis found no statistically significant benefit for fatigue (SMD: -0.33; P = 0.54), though only two trials measured this outcome and the heterogeneity between them was very high (I² = 89%), meaning the studies were measuring quite different things in quite different ways [3]. We’ll come back to this.
Evidence grade: Promising, reviewed evidence across multiple conditions, mechanism is well-supported
One of the most striking recent developments in CoQ10 research is the growing body of evidence connecting mitochondrial dysfunction, and specifically CoQ10 deficiency, to the overlapping cluster of conditions that produce profound cognitive fog alongside physical exhaustion [4] [8].
A 2025 review published in the *International Journal of Molecular Sciences* examined Gulf War Illness, fibromyalgia, ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome), and long COVID together, and found a striking overlap in their underlying biology [4]. Common features across all four conditions included mitochondrial dysfunction, oxidative stress, neuroinflammation, and immune dysregulation. The authors identified a clear rationale for CoQ10 supplementation across this group, noting that it functions as an antimitochondrial dysfunction agent, an antioxidant, and an anti-inflammatory compound simultaneously [4].
A 2024 overview focused specifically on post-viral fatigue syndrome reached similar conclusions, noting that accumulated literature has identified a direct link between mitochondrial dysfunction and low-grade systemic inflammation in ME/CFS, fibromyalgia, and long COVID, and that CoQ10’s role in cellular bioenergetic metabolism makes it a genuinely promising therapeutic candidate [8].
This matters for brain fog specifically because cognitive impairment is one of the defining features of all these conditions. When the mitochondria in brain cells aren’t producing energy efficiently, clear thinking becomes physiologically harder, not a weakness of character, but a measurable biological problem [8].
Evidence grade: Early stage to Promising, strong animal and mechanistic data, human trials ongoing
Beyond everyday cognitive fog, there is a substantial body of research exploring CoQ10’s potential role in protecting against neurodegenerative diseases, conditions like Parkinson’s, Alzheimer’s, Huntington’s, and migraine.
A comprehensive 2023 review covering CoQ10 across neurological diseases noted that since the early 1980s, research has consistently linked CoQ10 deficiency to cardiovascular, neurological, and cancer disorders [6]. The review found promising findings in migraine prevention, and in slowing aspects of Parkinson’s disease progression, though it was honest that CoQ10 supplementation has, in some cases, performed better in animal models than in human trials [10].
A separate 2025 review focused specifically on Parkinson’s disease outlined the mechanism in detail: CoQ10 acts as an essential electron carrier in the mitochondrial electron transport chain, reduces oxidative stress, and may protect dopaminergic neurons, the specific neurons that are progressively lost in Parkinson’s, from degeneration [2] [13]. The authors called for more research to establish optimal formulations and dosing to slow disease progression [2].
In animal research, CoQ10 has also shown promise in protecting against cognitive impairment caused by chemotherapy, the so-called “chemobrain” phenomenon, by reducing oxidative stress and mitochondrial dysfunction in the brain [9]. That’s animal data only, but the mechanism it supports is relevant to ageing brains more broadly.
A 2019 study combining transcranial photobiomodulation (a light therapy technique) with CoQ10 in ageing rat models found that the combination improved learning, memory, and neuroinflammation markers, and that mitochondrial biogenesis (the process of making new mitochondria) was a key pathway involved [12]. Again, animal study, but the biology is coherent.
This is the section that honest science writing demands, and it matters.
The fatigue question is genuinely unresolved. The meta-analysis that found CoQ10 modestly improves depression found no significant benefit for fatigue [3]. That might seem paradoxical given everything above, but the fatigue finding was based on only two trials with very high heterogeneity between them. This doesn’t mean CoQ10 doesn’t help fatigue, it means we don’t yet have the studies to say confidently that it does in a general population.
Most brain fog research isn’t in healthy middle-aged adults. The strongest human evidence is drawn from people with clinical conditions: depression, ME/CFS, long COVID, Parkinson’s, cancer treatment. The observational study linking CoQ10 to cognitive function in older adults is an important starting point, but we don’t yet have large RCTs specifically testing CoQ10 supplementation for cognitive fog in healthy 40–65-year-olds without a clinical diagnosis [7].
Animal models outpace human trials. Several of the most mechanistically compelling studies, on chemobrain, on ischaemic brain protection, on neuroinflammation and ageing, are in rodents [9] [12]. The biology is consistent and plausible, but the translation to human outcomes hasn’t always been confirmed.
Dosing and absorption remain open questions. CoQ10 is fat-soluble and relatively poorly absorbed in standard capsule form. Newer formulations, including ubiquinol (the pre-reduced form) and emulgel preparations, are being developed to improve bioavailability [5] [10], but optimal doses for cognitive outcomes in healthy adults haven’t been established through rigorous trials.
The causal direction in the observational data isn’t certain. The 2023 study showing that lower CoQ10 correlates with worse cognition in older adults doesn’t tell us whether low CoQ10 causes cognitive decline, or whether both are downstream of some other ageing process [7]. More longitudinal and intervention studies are needed.
Here’s what a sensible, informed person should actually take from all of this.
CoQ10 is a compound your body makes itself, needs for brain energy production, relies on as an antioxidant, and produces less of as you age. That basic biological reality is not in dispute. The research showing a link between low CoQ10 and reduced cognitive functioning in older adults, and the meta-analysis showing a moderate improvement in depressive symptoms across five RCTs, together form a reasonable foundation for considering supplementation, particularly if you’re over 40 and noticing any cognitive sluggishness, mood flatness or post-illness brain fog.
The evidence base here is *promising*, not *proven*. But here’s the practical logic: CoQ10 supplementation is well-tolerated and has no serious adverse effects at standard doses, even relatively high ones [10]. It’s fat-soluble, so it’s best taken with a meal that contains some fat to improve absorption. Typical doses in the research range from 100mg to 300mg daily, with higher doses used in specific neurological conditions.
Unlike iron, where supplementing without need can cause harm, CoQ10 has no known toxicity at normal supplementation levels. The risk/benefit calculation is genuinely favourable: declining natural production, a plausible mechanism, emerging human evidence, good safety profile.
If you’re in your 40s, 50s or 60s and experiencing brain fog, low energy, or mood that’s flatter than it used to be, particularly if you’ve been through a viral illness, are on a statin (which is known to deplete CoQ10 by blocking the same biosynthetic pathway), or simply want to support your brain’s energy infrastructure as you age, CoQ10 is one of the more evidence-grounded supplements worth considering as part of a broader approach to brain health.
The bigger picture: brain fog is rarely one thing. Mitochondrial dysfunction, oxidative stress, neuroinflammation, the research consistently clusters these together as features of cognitive decline, post-viral illness, and the ageing brain [4] [8]. CoQ10 addresses all three pathways. That’s not a miracle claim. It’s just good biology.
[1] Coenzyme Q, Neuroprotective Potential in Aging Rats (2025). DOI: 10.1007/s11011-025-01721-8 | https://pubmed.ncbi.nlm.nih.gov/41182484/
[2] Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling (2025). DOI: 10.1080/13813455.2025.2541698 | https://pubmed.ncbi.nlm.nih.gov/40762836/
[3] Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2026). DOI: 10.1097/JCP.0000000000002112 | https://pubmed.ncbi.nlm.nih.gov/41294251/
[4] Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies (2025). DOI: 10.3390/ijms26189044 | https://pubmed.ncbi.nlm.nih.gov/41009608/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12469932/
[5] A high-dose coenzyme Q10 oral emulgel formulation for patients with dysphagia and mitochondrial disease (2025). DOI: 10.1016/j.xphs.2025.103794 | https://pubmed.ncbi.nlm.nih.gov/40221093/
[6] Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases (2023). https://pubmed.ncbi.nlm.nih.gov/37946741/
[7] Coenzyme Q10 Levels Associated With Cognitive Functioning and Executive Function in Older Adults (2023). https://pubmed.ncbi.nlm.nih.gov/35908233/
[8] Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview (2024). https://pubmed.ncbi.nlm.nih.gov/38203745/
[9] Coenzyme Q10 ameliorates chemotherapy-induced cognitive impairment in mice: a preclinical study (2024). https://pubmed.ncbi.nlm.nih.gov/39174728/
[10] Coenzyme Q10 effects in neurological diseases (2021). DOI: 10.33549/physiolres.934712 | https://pubmed.ncbi.nlm.nih.gov/35199552/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054193/
[12] Photobiomodulation and Coenzyme Q10 in Aging and Ischemia (2019). DOI: 10.3389/fncel.2019.00074 | https://pubmed.ncbi.nlm.nih.gov/30983970/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434313/
[13] Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling (2025). DOI: 10.1080/13813455.2025.2541698 | https://pubmed.ncbi.nlm.nih.gov/40762836/
[14] Therapeutic Effects of Coenzyme Q10 in the Treatment of Ischemic Stroke (2024). https://pubmed.ncbi.nlm.nih.gov/39227555/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Struggling to find a word or remember someone’s name may feel like normal ageing, but research suggests it’s
Quick Read Chronic loneliness, the subjective feeling that your relationships don’t match what you need, physically damages your brain. Research
Free guide: The research behind brain health supplements
Plus our weekly research digest — straight to your inbox.
Just leave your email address.